West Pharmaceutical Services, Inc. (WST) Tops Q1 EPS by 16c; Raises FY Guidance
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q1 EPS of $0.81, $0.16 better than the analyst estimate of $0.65. Revenue for the quarter came in at $316.3 million versus the consensus estimate of $308.2 million.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.50-$2.67, versus prior guidance of $2.37-$2.55 and the consensus of $2.49. West Pharmaceutical Services, Inc. sees FY2012 revenue of $1.25-$1.28 billion, versus prior guidance of $1.215-$1.245 billion and the consensus of $1.23 billion.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.50-$2.67, versus prior guidance of $2.37-$2.55 and the consensus of $2.49. West Pharmaceutical Services, Inc. sees FY2012 revenue of $1.25-$1.28 billion, versus prior guidance of $1.215-$1.245 billion and the consensus of $1.23 billion.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.